Concord Drugs Standalone June 2024 Net Sales at Rs 6.35 crore, down 27.71% Y-o-Y
August 13, 2024 / 12:10 IST
Reported Standalone quarterly numbers for Concord Drugs are:Net Sales at Rs 6.35 crore in June 2024 down 27.71% from Rs. 8.79 crore in June 2023.
Quarterly Net Profit at Rs. 0.01 crore in June 2024 down 97.6% from Rs. 0.49 crore in June 2023.
EBITDA stands at Rs. 0.74 crore in June 2024 down 47.14% from Rs. 1.40 crore in June 2023.
Concord Drugs EPS has decreased to Rs. 0.01 in June 2024 from Rs. 0.52 in June 2023.
| Concord Drugs shares closed at 33.39 on August 12, 2024 (BSE) and has given -25.87% returns over the last 6 months and 6.24% over the last 12 months. |
| Concord Drugs | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Mar'24 | Jun'23 | | Net Sales/Income from operations | 6.35 | 14.47 | 8.79 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 6.35 | 14.47 | 8.79 | | EXPENDITURE | | Consumption of Raw Materials | 3.88 | 12.79 | 5.74 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 0.35 | -0.09 | 0.12 | | Power & Fuel | -- | -- | -- | | Employees Cost | 1.05 | 1.25 | 1.21 | | Depreciation | 0.34 | 0.39 | 0.38 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.34 | 0.32 | 0.31 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 0.40 | -0.20 | 1.02 | | Other Income | 0.00 | 0.00 | -- | | P/L Before Int., Excpt. Items & Tax | 0.40 | -0.20 | 1.02 | | Interest | 0.37 | 0.38 | 0.39 | | P/L Before Exceptional Items & Tax | 0.03 | -0.58 | 0.63 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 0.03 | -0.58 | 0.63 | | Tax | 0.01 | -0.22 | 0.14 | | P/L After Tax from Ordinary Activities | 0.01 | -0.35 | 0.49 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 0.01 | -0.35 | 0.49 | | Equity Share Capital | 10.00 | 10.00 | 9.32 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 0.01 | -0.35 | 0.52 | | Diluted EPS | 0.01 | -0.35 | 0.52 | | EPS After Extra Ordinary | | Basic EPS | 0.01 | -0.35 | 0.52 | | Diluted EPS | 0.01 | -0.35 | 0.52 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
